Skip to main
IDXX

IDEXX Laboratories (IDXX) Stock Forecast & Price Target

IDEXX Laboratories (IDXX) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 38%
Hold 38%
Sell 0%
Strong Sell 0%

Bulls say

IDEXX Laboratories is a top-performing company in the animal health industry with a global presence and a diverse product portfolio including diagnostic test kits, lab services, and software solutions. The company has consistently achieved strong financial results with double-digit EPS growth and is well-positioned to benefit from the growing trend of "humanization of pets". While there are potential risks, such as negative media attention, the company's CEO transition and new product launches are expected to drive further growth. Additionally, the industry itself is expected to rebound, which could further boost IDEXX's performance.

Bears say

IDEXX Laboratories is a company with a strong product line and high recurring revenue, specifically in its core companion animal group segment, which represents 90% of its total revenue. While the animal health industry has significant growth potential, IDXX may face challenges such as potential supply chain disruptions and government regulations. However, with its market leadership and investments in research and development, IDXX is well-positioned for long-term secular growth.

IDEXX Laboratories (IDXX) has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 38% recommend Buy, 38% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IDEXX Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IDEXX Laboratories (IDXX) Forecast

Analysts have given IDEXX Laboratories (IDXX) a Buy based on their latest research and market trends.

According to 8 analysts, IDEXX Laboratories (IDXX) has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $743.12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $743.12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IDEXX Laboratories (IDXX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.